License: Open Access by International Journal of Proteomics & Bioinformatics is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at SciRes Literature..
Manuscript should be submitted in Word Document (.doc or .docx) through online form or can be mailed to the particular journal's E-mail ID or to submit@scireslit.com, scireslit@gmail.com
Research Articles
Articles
Our Vision
Author Feedback
Hanna Balakier
Hanna Balakier, CReATe Fertility Centre, Toronto, ON, Canada
Meysoon Adil Abdelrahman Elagib
Senior Resident of Internal Medicine, Khartoum, Sudan
I am very happy with your editing of the article. The structure is very appealing and the coloring fits the topic well.
I especially like the design of the tables.
I am looking forward for future publications.
International Journal of Virology & Infectious Diseases
Frauke Elbnik
Christian-Albrechts University, Germany
I am very glad to mention that Scireslit worked in close coordination with me to enable me successfully to complete my article for their journal and thereby enabled me to share my ideas with other researchers and scientists. The team is very responsive and knowledgeable. This platform has provided me an opportunity to collaborate my learning with other subject matter experts in the field of healthcare. Thanks to the entire Scireslit team
Rayees.Y.Sheikh
Nephrologist, Fellowship in Advanced Hemodialysis - Canada
SciRes not only ensures that the articles can be published smoothly, but make sure there are readers' market for my articles as they are easily accessible. I can also improve the lack of research through the results of the peer review system. The diversity of expertise in the editorial board ensures the continuity and smoothness of future publications in order to raise the level of public reading in general and assist the next author's research.
Uqbah Iqbal
Socioeconomic Researcher, Research for Social Advancement, Malaysia
Michael AB Naafs
Interrnist-Endocrinologist at Naafs International Health Consultancy, The Netherlands
International Journal of Clinical Endocrinology has a good Editorial Team!!!
Mario Ciampolini
University of Florence, Italy
Dear Rose, The Editorial services are perfect.
Angelou An.
Dr. Anastasios Angelou
Health center Alexandras, Athens, Greece
I have been very pleased with your publication process. It is very thorough and very professionally done. There was very dedicated reviewer and editorial process to ensure a very high scientific standard is achieved when a manuscript is accepted by your journal through the very disciplined peer review process. The overall management and integrity of the publisher is deserving of high praise. I wish you every success.
Prof. Woo Keng Thye
Dept of Renal Medicine, Singapore General Hospital, Singapore
Starting from the process of preparing the manuscripts and until the release of the electronic version of the articles, I felt a benevolent attitude towards our work and I was sure that I was dealing with high-level professionals. All problems encountered were resolved as soon as possible. I sincerely wish prosperity to your publishing house and the journals mentioned above.
Alexander Naumkin
Senior Scientist of X-ray Diffraction, A.N.Nesmeyanov Institute of Organoelement Compounds, Russia
Pedro Jose Gonzalez Matarin
Professor of Sports and Exercise in University of Almeria, Spain
The publication process in the America Journal of Nanotechnology & Nanomedicine is simple, fast and of good quality. I wish the Journal a successful futureI was very satisfied with the performance of the editorial team. The paper was processed very quickly and uploaded to the homepage.
Cordin Arpagaus
University in Buchs, SwitzerlandClaudio Carini
Pfizer Inc, USA
Dr. Carini has a strong passion in the application of biomarkers in translational medicine and personalized healthcare.
Dr. Carini is currently appointed Global Head of Clinical Immunology and Biomarkers” at Pfizer Inc. and holds a Hon. Professor Position at King’s College, School of Medicine, Univ. of London.
Dr. Carini is a strong believer of open innovation networks, and in his roles he has been collaborating intensely with pharmaceutical, biotechnological, and diagnostic industries, SMEs, biobanks, clinicians, technology providers and information specialists to accelerate applied scientific research through public-private partnerships. His technical expertise resides most strongly in molecular profiling methods (genetics, transcriptomics, proteomics, metabolomics, bioinformatics), in analytical biomarker development, and applications in translational scientific research
His professional background is a mix of academia, pharmaceutical industry, applied research institute, university medical center. He has been leading technology-based biomarker laboratories, cross-functional expert teams, therapeutic project teams and being involved into public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of therapeutic areas. While working globally he has contributed to over 200 projects in various phases of biomarker R&D. Claudio is a strong believer of open innovation networks, and in his roles he has been collaborating with several stakeholders to accelerate applied scientific research through public-private partnerships. His technical expertise resides most strongly in molecular profiling, analytical biomarker development, and applications in translational scientific research.
Dr. Carini obtained his MD in Italy. Later, he earned the PhD in Immunology from the University College London (UCL), University of London and subsequently an FRCPath in Immunology from the Royal College of Pathologists, London and Specialists Diplomas for Clinical Immunology and Respiratory Medicine from the University of Rome.
Previously Dr Carini held Senior roles in several Pharma Companies (Wyeth, Novartis, Roche) and Faculty positions at Harvard, Johns Hopkins, UCL, and Rome Univ
Dr Carini is serving in several national and international scientific boards:
F-NIH Biomarkers Consortium Inflammation/Immunology Steering Committee
MRC, UK) “Inflammation/ Immunology Initiative - UK Rheumatoid Arthritis Consortium, Steering Committee
MRC, (UK) “Stratified Medicine, SLE Consortium, Steering Committee
Biomarkers Development Center, Amsterdam, NL, Advisory Board
IMI, ABIRISK, European Union/EFPIA” Board of Directors
The PML Consortium, Board of Directors